Dr. Shet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Building 10, Room 6s241, Msc 1589
Bethesda, MD 20892Phone+1 301-827-6631
Education & Training
St. John's Medical CollegeClass of 1993, MB BS
Certifications & Licensure
MD State Medical License 2016 - 2025
Clinical Trials
- Blood Collection for Research Related to Certain Diseases Involving Blood Vessels Start of enrollment: 2002 Nov 04
- Study of Blood Platelets in Sickle Cell Disease Start of enrollment: 2005 Aug 01
Publications & Presentations
PubMed
- 1 citationsNon-invasive optical and laboratory hematologic biomarkers correlate in patients with sickle cell disease.Timothy Quang, Golnar Mostashari, Elise Berning, Bindu Parachalil Gopalan, Maria A Lizarralde-Iragorri
Biomedical Optics Express. 2024-08-01 - 1 citationsR406 reduces lipopolysaccharide-induced neutrophil activation.Seth Warner, Heather L Teague, Marcos J Ramos-Benitez, Sumith Panicker, Kiana Allen
Cellular Immunology. 2024-07-26 - 2 citationsIsoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial.Maria A Lizarralde-Iragorri, Bindu Parachalil Gopalan, Brenda Merriweather, Jennifer Brooks, Mai Hill
Blood Advances. 2024-01-09
Press Mentions
The Dynamic Association Between COVID-19 and Chronic Disorders: An Updated Insight into Prevalence, Mechanisms and Therapeutic ModalitiesNovember 29th, 2020- Review the Dynamic Association Between COVID-19 and Chronic Disorders: An Updated Insight into Prevalence, Mechanisms and Therapeutic ModalitiesNovember 29th, 2020
Grant Support
- Human Specimen Collection to Support Basic and Clinical ResearchNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- A Phase 1 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects with stable sickle cell diseaseNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell DiseaseNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell DiseaseNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
